Navigation Links
Excaliard Pharmaceuticals Appoints Jay Birnbaum, Ph.D. to the Board of Directors.
Date:7/31/2009

CARLSBAD, Calif., July 31 /PRNewswire/ -- Excaliard Pharmaceuticals, a late stage preclinical company developing targeted therapeutics for the treatment of skin scarring and fibrotic disorders, is pleased to announce that Jay Birnbaum, Ph.D. has joined the Board of Directors as an Independent Board Member.

Dr. Jay Birnbaum is a dermatology consultant specializing in ethical and OTC drugs, medical devices, and cosmeceuticals. His 35 years of industry experience span the areas of discovery research, formulations, clinical R&D, regulatory and marketing, and he has been involved in the development and commercialization of numerous drug and consumer products and brands. Dr. Birnbaum is a co-founder and former Chief Medical Officer of Kythera Biopharmaceuticals, a company developing products in aesthetic dermatology. Prior to starting his own consulting company in 1999, he was with Novartis/Sandoz Pharmaceuticals Corporation, serving most recently as Vice President, Global Project Management, with responsibilities for strategic planning and development of the company's dermatology portfolio. Prior to that, Dr. Birnbaum held various management positions at the Medical and Consumer Product Divisions of American Cyanamid Company (Wyeth).

Dr. Birnbaum has broad relationships in industry and academia, and has published extensively on his work in drug development. His professional affiliations include the American Academy of Dermatology, Society of Investigative Dermatology, European Academy of Dermatology and Venereology, American Society for Dermatologic Surgery, and International Society of Dermatology. He is a member of the board of directors of Oculus Innovative Sciences, Inc. and is on the Science Advisory Boards of Evolva, NanoBio Corp, NexMed, Inc., Topica Pharmaceuticals, and Transport Pharmaceuticals.

He received a B.S. degree from Trinity College and a Ph.D in Pharmacology from the University of Wisconsin.

Excaliard Pharmaceuticals, Inc,(R) is delighted to have an individual with Jay's technical and business experience join the Board of Directors and looks forward to his many contributions.


'/>"/>
SOURCE Excaliard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
2. Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
3. ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2009 Financial Results
4. Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
5. Poniard Pharmaceuticals to Present at Two Upcoming Investor Conferences in August
6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
7. Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
8. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
9. Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
10. Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
11. Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 top five ... art competition. Selected from 15 submissions from around the nation, the top five finalists ... iaedp Symposium, March 22 – 26 in Las Vegas. , This year, the competition ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle ... hosted their Military Wedding Giveaway, with the winning couple announced on Feb. 14, ... services generously donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... Mass. (PRWEB) , ... February 23, 2017 , ... ... as an approved content provider for the National Institute for Health and ... and social care-related organizations in the National Health Service (NHS) to search, order ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... announced today that it will soon begin franchising throughout the U.S. starting this ... to help bring the practice of meditation mainstream. Current Meditation will be the ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... BRISBANE, Australia , Feb. 23, 2017  Directors from Pharma ... the two companies have joined forces, resulting in the founding of ... . Pharma To Market are pleased to announce their ... an office in Singapore . The company are ... Consulting as Co-Director of the Singapore based ...
(Date:2/24/2017)... Feb 24, 2017 Medivir AB ... for a new Board of Directors that will be ... Nomination Committee comprises representatives of the company,s three largest ... 2016 who have accepted a seat on the Nomination ... of the 2016-2017 Nomination Committee was as follows:  ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Autism ... to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis and ... global Autism Spectrum Disorder market. The research answers the following ... marketed for Autism Spectrum Disorder and their clinical attributes? How are ...
Breaking Medicine Technology: